NDAORALTABLET
Approved
Oct 1972
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
DARVOCET (acetaminophen; propoxyphene hydrochloride) by Teva. Approved for minor aches, pains due to: headache sore throat flu toothache the common cold temporarily reduces fever. First approved in 1972.
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Darvocet is an oral combination analgesic tablet containing acetaminophen and propoxyphene hydrochloride, approved in 1972 for treating minor aches and pains including headache, sore throat, toothache, and cold symptoms. It also temporarily reduces fever. The precise mechanism is not fully established but involves central analgesic and antipyretic actions.
LOE Approaching
As a product approaching loss of exclusivity with competitive pressure rated at 30, team sizes and investment are likely contracting, signaling reduced advancement opportunities on the brand team.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Worked on DARVOCET at Teva? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.